Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy
NCT07831746Phase 3Not yet recruiting
- Start
- Apr 2027
- Primary completion
- Sep 2032
01
Overview
Phase 3, randomised, double-blind trial in hypoxic ischemic brain injury (HIBI), perinatal arterial ischemic stroke (PAIS) and perinatal asphyxia (2 arms). Primary endpoint: Motor composite score of the Bayley Scales of Infant and Toddler Development 4th Edition at 24 months. Planned start Apr 2027; status: not yet recruiting.
02
Conditions
hypoxic ischemic brain injury (HIBI)perinatal arterial ischemic stroke (PAIS)perinatal asphyxia
Beyond the preview
Go deeper on NCT07831746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07831746.